Translation Initiation Factors: Reprogramming Protein Synthesis in Cancer

被引:104
作者
Chu, Jennifer [1 ]
Cargnello, Marie [2 ,3 ]
Topisirovic, Ivan [1 ,2 ,3 ]
Pelletier, Jerry [1 ,3 ,4 ]
机构
[1] McGill Univ, Dept Biochem, Montreal, PQ, Canada
[2] McGill Univ, Lady Davis Inst, SMBD JGH, Montreal, PQ, Canada
[3] McGill Univ, Gerald Bronfman Dept Oncol, Montreal, PQ, Canada
[4] McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ, Canada
基金
加拿大健康研究院; 美国国家卫生研究院;
关键词
CAP-DEPENDENT TRANSLATION; TRANSFORMATION SUPPRESSOR PDCD4; GUANINE-NUCLEOTIDE EXCHANGE; MESSENGER-RNA TRANSLATION; EUKARYOTIC INITIATION; MALIGNANT-TRANSFORMATION; CELL-SURVIVAL; FACTOR; 4B; GENE AMPLIFICATION; ER STRESS;
D O I
10.1016/j.tcb.2016.06.005
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Control of mRNA translation plays a crucial role in the regulation of gene expression and is critical for cellular homeostasis. Dysregulation of translation initiation factors has been documented in several pathologies including cancer. Aberrant function of translation initiation factors leads to translation reprogramming that promotes proliferation, survival, angiogenesis, and metastasis. In such context, understanding how altered levels (and presumably activity) of initiation factors can contribute to tumor initiation and/or maintenance is of major interest for the development of novel therapeutic strategies. In this review we provide an overview of translation initiation mechanisms and focus on recent findings describing the role of individual initiation factors and their aberrant activity in cancer.
引用
收藏
页码:918 / 933
页数:16
相关论文
共 205 条
[1]   eIF4E/4E-BP Ratio Predicts the Efficacy of mTOR Targeted Therapies [J].
Alain, Tommy ;
Morita, Masahiro ;
Fonseca, Bruno D. ;
Yanagiya, Akiko ;
Siddiqui, Nadeem ;
Bhat, Mamatha ;
Zammit, Domenick ;
Marcus, Victoria ;
Metrakos, Peter ;
Voyer, Lucie-Anne ;
Gandin, Valentina ;
Liu, Yi ;
Topisirovic, Ivan ;
Sonenberg, Nahum .
CANCER RESEARCH, 2012, 72 (24) :6468-6476
[2]   mTOR signaling in cellular and organismal energetics [J].
Albert, Verena ;
Hall, Michael N. .
CURRENT OPINION IN CELL BIOLOGY, 2015, 33 :55-66
[3]   Translation of 5' leaders is pervasive in genes resistant to eIF2 repression [J].
Andreev, Dmitry E. ;
O'Connor, Patrick B. F. ;
Fahey, Ciara ;
Kenny, Elaine M. ;
Terenin, Ilya M. ;
Dmitriev, Sergey E. ;
Cormican, Paul ;
Morris, Derek W. ;
Shatsky, Ivan N. ;
Baranov, Pavel V. .
ELIFE, 2015, 4
[4]   A multifactor complex of eukaryotic initiation factors, eIE1, eIF2, eIF3, eIF5, and initiator tRNAMet is an important translation initiation intermediate in vivo [J].
Asano, K ;
Clayton, J ;
Shalev, A ;
Hinnebusch, AG .
GENES & DEVELOPMENT, 2000, 14 (19) :2534-2546
[5]   The translation initiation factor eIF3-p48 subunit is encoded by int-6, a site of frequent integration by the mouse mammary tumor virus genome [J].
Asano, K ;
Merrick, WC ;
Hershey, JWB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (38) :23477-23480
[6]   Why is start codon selection so precise in eukaryotes? [J].
Asano, Katsura .
TRANSLATION, 2014, 2 (01)
[7]   Characterization of a Novel PERK Kinase Inhibitor with Antitumor and Antiangiogenic Activity [J].
Atkins, Charity ;
Liu, Qi ;
Minthorn, Elisabeth ;
Zhang, Shu-Yun ;
Figueroa, David J. ;
Moss, Katherine ;
Stanley, Thomas B. ;
Sanders, Brent ;
Goetz, Aaron ;
Gaul, Nathan ;
Choudhry, Anthony E. ;
Alsaid, Hasan ;
Jucker, Beat M. ;
Axten, Jeffrey M. ;
Kumar, Rakesh .
CANCER RESEARCH, 2013, 73 (06) :1993-2002
[8]   Activation of translation complex eIF4F is essential for the genesis and maintenance of the malignant phenotype in human mammary epithelial cells [J].
Avdulov, S ;
Li, S ;
Michalek, V ;
Burrichter, D ;
Peterson, M ;
Perlman, DM ;
Manivel, JC ;
Sonenberg, N ;
Yee, D ;
Bitterman, PB ;
Polunovsky, VA .
CANCER CELL, 2004, 5 (06) :553-563
[9]   DNA damage and eIF4G1 in breast cancer cells reprogram translation for survival and DNA repair mRNAs [J].
Badura, Michelle ;
Braunstein, Steve ;
Zavadil, Jiri ;
Schneider, Robert J. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (46) :18767-18772
[10]   Hypusination of eukaryotic imtiation factor 5A (eIF5A):: a novel therapeutic target in BCR-ABL-positive leukemias identified by a proteomics approach [J].
Balabanov, Stefan ;
Gontarewicz, Artur ;
Ziegler, Patrick ;
Hartmann, Ulrike ;
Kammer, Winfried ;
Copland, Mhairi ;
Brassat, Ute ;
Priemer, Martin ;
Hauber, Ilona ;
Wilhelm, Thomas ;
Schwarz, Gerold ;
Kanz, Lothar ;
Bokemeyer, Carsten ;
Hauber, Joachim ;
Holyoake, Tessa L. ;
Nordheim, Alfred ;
Bruemmendorf, Tim H. .
BLOOD, 2007, 109 (04) :1701-1711